Hantz Financial Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Buy
1,007
+91
+10% +$17.9K ﹤0.01% 1077
2026
Q1
$180K Buy
916
+81
+10% +$15.7K ﹤0.01% 1032
2025
Q4
$145K Buy
835
+73
+10% +$13.3K ﹤0.01% 994
2025
Q3
$145K Buy
762
+293
+62% +$52K ﹤0.01% 852
2025
Q2
$84K Buy
+469
New +$81.5K ﹤0.01% 806
2024
Q4
Sell
-437
Closed -$68K 1118
2024
Q3
$68K Hold
437
﹤0.01% 638
2024
Q2
$60K Buy
+437
New +$59.8K ﹤0.01% 644
2021
Q1
Sell
-672
Closed -$80K 703
2020
Q4
$80K Buy
+672
New +$81.9K ﹤0.01% 475

Other funds holding DGX

Hantz Financial Services's DGX Position: Q2 2026 in Review

Hantz Financial Services increased its Quest Diagnostics (DGX) stake by 9.9% in Q2 2026, buying an estimated $17.9K and bringing the position to 1,007 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Hantz Financial Services first reported a position in DGX in Q4 2020 and has held it in 8 quarters since. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Hantz Financial Services held 1,007 shares of Quest Diagnostics worth $213K as of Q2 2026.
  • Hantz Financial Services bought 91 Quest Diagnostics shares in Q2 2026, an estimated $17.9K.
  • Quest Diagnostics made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1077 holding.
  • Hantz Financial Services first reported a position in Quest Diagnostics in Q4 2020 and has held it in 8 quarters since.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.